Published June 30, 2021, 6:38 AM
NEW DELHI, India – India authorized the emergency use of Moderna’s COVID-19 vaccine on Tuesday as it seeks to ramp up inoculations in the wake of a record-breaking surge in infections and deaths.
A health worker inoculates a woman with a dose of the Covaxin vaccine against the Covid-19 coronavirus inside the premises of the Golden Temple in Amritsar on June 29, 2021.
NARINDER NANU / AFP The vast nation of 1.3 billion people was hit by a massive spike in coronavirus cases in April and May that pushed the healthcare system to breaking point. Moderna’s shot is the fourth to be approved by New Delhi after Oxford-AstraZeneca’s Covishield and Covaxin which was developed by Indian firm Bharat Biotech and Russia’s Sputnik V.
Sewage Surveillance: Why Wastewater Testing Is An Essential Tool In A Pandemic swarajyamag.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from swarajyamag.com Daily Mail and Mail on Sunday newspapers.
Image used for representational purpose only
HYDERABAD: Analysis of the SARS-CoV-2 virus has revealed that the B.1.525 variant, which was first reported in the UK in February this year, has presence in Telangana.
Enlisted as the variant of interest by the World Health Organization (WHO), out of the 22 samples randomly analysed in April and May in the country, 16 were found in Telangana.
This variant was also discovered in Australia and Denmark and has been linked to people travelling to Nigeria and getting infected.
“This variety is already present in almost 50 countries and been declared variant of interest out of six variants of interest of Covid-19 in the world. If a region is displaying samples, we need to observe the trend more carefully,” a senior specialist in genome sequencing from Bangalore said.